Skip to Content

OP 100 (Lynparza 100 mg)

Generic Name: olaparib

Pill with imprint OP 100 is Yellow, Elliptical / Oval and has been identified as Lynparza 100 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Lynparza is used in the treatment of ovarian cancer; pancreatic cancer; breast cancer, metastatic; prostate cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for OP 100

Lynparza 100 mg OP 100

Lynparza

Generic Name
olaparib
Imprint
OP 100
Strength
100 mg
Color
Yellow
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
PARP inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC)
00310-0668
Inactive Ingredients
hypromelloses, titanium dioxide, polyethylene glycol 400, ferric oxide yellow, water, ferrosoferric oxide, copovidone, silicon dioxide, mannitol, sodium stearyl fumarate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "OP 100"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.